• Tue, August 8, 2023
Douglas Tsao Reiterated (TBPH) at Strong Buy and Held Target at $20 on, Aug 8th, 2023
Douglas Tsao of HC Wainwright & Co., Reiterated "Theravance Biopharma, Inc." (TBPH) at Strong Buy and Held Target at $20 on, Aug 8th, 2023.
Douglas, nor any peers, have made any analyst calls on TBPH in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30